APA (7th ed.) Citation

Guttman-Yassky, E., Simpson, E., Esfandiari, E., Mano, H., Bauer, J., Charuworn, P., & Kabashima, K. (2025). Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis. Dermatology & Therapy, 15(11), 3153. https://doi.org/10.1007/s13555-025-01492-1

Chicago Style (17th ed.) Citation

Guttman-Yassky, Emma, Eric Simpson, Ehsanollah Esfandiari, Hirotaka Mano, Jillian Bauer, Prista Charuworn, and Kenji Kabashima. "Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis." Dermatology & Therapy 15, no. 11 (2025): 3153. https://doi.org/10.1007/s13555-025-01492-1.

MLA (9th ed.) Citation

Guttman-Yassky, Emma, et al. "Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis." Dermatology & Therapy, vol. 15, no. 11, 2025, p. 3153, https://doi.org/10.1007/s13555-025-01492-1.